Lv11
40 积分 2025-10-10 加入
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
1个月前
已完结
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
1个月前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
2个月前
已完结
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
2个月前
已完结
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
